COVID-19 Molecular Testing in Korea: Practical Essentials and Answers From Experts Based on Experiences of Emergency Use Authorization Assays
2
조회
0
다운로드
19
인용
0
참고문헌
키워드
초록
Coronavirus disease 2019 (COVID-19) is a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Early detection of COVID-19 and immediate isolation of infected patients from the naive population are important to prevent further pandemic spread of the infection. Real-time reverse transcription (RT)-PCR to detect SARS-CoV-2 RNA is currently the most reliable diagnostic method for confirming COVID-19 worldwide. Guidelines for clinical laboratories on the COVID-19 diagnosis have been recently published by Korean Society for Laboratory Medicine and the Korea Centers for Disease Control and Prevention. However, these formal guidelines do not address common practical laboratory issues related to COVID-19 real-time RT-PCR testing and their solutions. Therefore, this guideline is intended as a practical and technical supplement to the “Guidelines for Laboratory Diagnosis of COVID-19 in Korea”.
Abstract
Coronavirus disease 2019 (COVID-19) is a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Early detection of COVID-19 and immediate isolation of infected patients from the naive population are important to prevent further pandemic spread of the infection. Real-time reverse transcription (RT)-PCR to detect SARS-CoV-2 RNA is currently the most reliable diagnostic method for confirming COVID-19 worldwide. Guidelines for clinical laboratories on the COVID-19 diagnosis have been recently published by Korean Society for Laboratory Medicine and the Korea Centers for Disease Control and Prevention. However, these formal guidelines do not address common practical laboratory issues related to COVID-19 real-time RT-PCR testing and their solutions. Therefore, this guideline is intended as a practical and technical supplement to the “Guidelines for Laboratory Diagnosis of COVID-19 in Korea”.
참고문헌 (18)
- "Naming the coronavirus disease (COVID-19) and the virus that causes it"[URL]
- "WHO Director-General’s opening remarks at the media briefing on COVID-19"[URL]
- Ki Ho Hong, "Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea", Annals of Laboratory Medicine, 40(5), pp.351~360 (2020), 대한진단검사의학회[DOI]
- "Interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19)"[URL]
- "Coronavirus disease (COVID-19) technical guidance: laboratory testing for 2019-nCoV in humans"[URL]
- Wang X, "Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously", Int J Infect Dis, 94, pp.107~109 (2020)
- 성흥섭, "Comparative Evaluation of Three Homogenization Methods for Isolating Middle East Respiratory Syndrome Coronavirus Nucleic Acids From Sputum Samples for Real-Time Reverse Transcription PCR", Annals of Laboratory Medicine, 36(5), pp.457~462 (2016), 대한진단검사의학회
- Pan Y, "Potential false-negative nucleic acid testing results for severe acute respiratory syndrome coronavirus 2 from thermal inactivation of samples with low viral loads", Clin Chem (2020)[DOI]
- Yen-Lieberman B, "Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories", J Clin Microbiol, 34, pp.2695~2701 (1996)
- Kim S, "Comparative evaluation of two automated systems for nucleic acid extraction of BK virus : NucliSens easyMAG versus BioRobot MDx", J Virol Methods, 162, pp.208~212 (2009)
- "Q&A for COVID-19 testings"[URL]
- Sung H, "Preparedness and rapid implementation of external quality assessment helped quickly increase COVID-19 testing capacity in the Republic of Korea", Clin Chem (2020)[DOI]
- Corman VM, "Detection of 2019 novel coronavirus(2019-nCoV)by real-time RT-PCR", Euro Surveill, 25, pp.2000045~ (2020)
- CLSI, "Establishing molecular testing in clinical laboratory environments; approved guideline" (2011), Clinical and Laboratory Standards Institute
- Park GW, "Swab sampling method for the detection of human norovirus on surface", J Vis Exp, 120, pp.55205~ (2017)
- "Distinguishing-real-signal-from-background-noise-ask-taqman-41"[URL]
- "Management guidelines for coronavirus disease-19. Version 8"[URL]
- "Criteria for return to work for healthcare personnel with suspected or confirmed COVID-19 (Interim Guidance)"[URL]